CL2007001388A1 - Co-cristal de maleato de 2{etil[3-({4-[(5-{2-[(3-fluorfenil)amino]-2-oxoetil}-1h-pirazol-3-il)amino]quinazolin-7-il}oxi)propil]amino}fosfato dihidrogeno de etilo (azd1152), inhibidor de aurora quinasa; metodo de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades hiperproliferativas como el cancer. - Google Patents
Co-cristal de maleato de 2{etil[3-({4-[(5-{2-[(3-fluorfenil)amino]-2-oxoetil}-1h-pirazol-3-il)amino]quinazolin-7-il}oxi)propil]amino}fosfato dihidrogeno de etilo (azd1152), inhibidor de aurora quinasa; metodo de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades hiperproliferativas como el cancer.Info
- Publication number
- CL2007001388A1 CL2007001388A1 CL2007001388A CL2007001388A CL2007001388A1 CL 2007001388 A1 CL2007001388 A1 CL 2007001388A1 CL 2007001388 A CL2007001388 A CL 2007001388A CL 2007001388 A CL2007001388 A CL 2007001388A CL 2007001388 A1 CL2007001388 A1 CL 2007001388A1
- Authority
- CL
- Chile
- Prior art keywords
- amino
- ethyl
- azd1152
- fluorphenyl
- quinazolin
- Prior art date
Links
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title abstract 4
- -1 5- {2 - [(3-fluorphenyl) amino] -2-oxoethyl} -1h-pyrazol-3-yl Chemical group 0.000 title abstract 2
- GBJVVSCPOBPEIT-UHFFFAOYSA-N AZT-1152 Chemical compound N=1C=NC2=CC(OCCCN(CC)CCOP(O)(O)=O)=CC=C2C=1NC(=NN1)C=C1CC(=O)NC1=CC=CC(F)=C1 GBJVVSCPOBPEIT-UHFFFAOYSA-N 0.000 title abstract 2
- 229940123877 Aurora kinase inhibitor Drugs 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 239000003719 aurora kinase inhibitor Substances 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 239000013078 crystal Substances 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title abstract 2
- 230000003463 hyperproliferative effect Effects 0.000 title abstract 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 title abstract 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0609621.8A GB0609621D0 (en) | 2006-05-16 | 2006-05-16 | Novel co-crystal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2007001388A1 true CL2007001388A1 (es) | 2008-01-18 |
Family
ID=36637528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2007001388A CL2007001388A1 (es) | 2006-05-16 | 2007-05-15 | Co-cristal de maleato de 2{etil[3-({4-[(5-{2-[(3-fluorfenil)amino]-2-oxoetil}-1h-pirazol-3-il)amino]quinazolin-7-il}oxi)propil]amino}fosfato dihidrogeno de etilo (azd1152), inhibidor de aurora quinasa; metodo de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades hiperproliferativas como el cancer. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7625910B2 (https=) |
| EP (1) | EP2027114A1 (https=) |
| JP (1) | JP2009537498A (https=) |
| KR (1) | KR20090009297A (https=) |
| CN (1) | CN101448823A (https=) |
| AR (1) | AR060963A1 (https=) |
| AU (1) | AU2007251304A1 (https=) |
| BR (1) | BRPI0712791A2 (https=) |
| CA (1) | CA2650519A1 (https=) |
| CL (1) | CL2007001388A1 (https=) |
| EC (1) | ECSP088890A (https=) |
| GB (1) | GB0609621D0 (https=) |
| IL (1) | IL194862A0 (https=) |
| MX (1) | MX2008014550A (https=) |
| NO (1) | NO20084580L (https=) |
| RU (1) | RU2008149242A (https=) |
| SA (1) | SA07280243B1 (https=) |
| TW (1) | TW200813026A (https=) |
| UA (1) | UA95108C2 (https=) |
| UY (1) | UY30351A1 (https=) |
| WO (1) | WO2007132227A1 (https=) |
| ZA (1) | ZA200809172B (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60234125D1 (de) * | 2001-12-24 | 2009-12-03 | Astrazeneca Ab | E inhibitoren |
| MXPA05012377A (es) * | 2003-05-15 | 2006-05-25 | Arqule Inc | Derivados de imidazotiazoles e imidazoxazol como inhibidores de p38. |
| JP2008517064A (ja) * | 2004-10-19 | 2008-05-22 | アークル インコーポレイテッド | Ｐ３８ｍａｐキナーゼのイミダゾオキサゾールおよびイミダゾチアゾール阻害剤の合成 |
| EP2013218A2 (en) * | 2006-04-17 | 2009-01-14 | Arqule, Inc. | Raf inhibitors and their uses |
| CN102317293A (zh) * | 2008-12-05 | 2012-01-11 | 艾科尔公司 | Raf抑制剂及其用途 |
| HUE024568T2 (hu) * | 2009-09-11 | 2016-02-29 | Amgen Inc | N-(4-((3-(2-amino-4-pirimidinil)-2-piridinil)oxi)fenil)-4-(4-metil-2-tienil)-1-ftalazinamin antimitotikus szerre rezisztens rák kezelésében történõ alkalmazásra |
| GB201007286D0 (en) | 2010-04-30 | 2010-06-16 | Astex Therapeutics Ltd | New compounds |
| GB201020179D0 (en) | 2010-11-29 | 2011-01-12 | Astex Therapeutics Ltd | New compounds |
| GB201118652D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
| GB201118675D0 (en) | 2011-10-28 | 2011-12-14 | Astex Therapeutics Ltd | New compounds |
| GB201118656D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
| GB201118654D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
| GB201209613D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
| GB201209609D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
| GB201307577D0 (en) | 2013-04-26 | 2013-06-12 | Astex Therapeutics Ltd | New compounds |
| ES2640648T3 (es) * | 2013-09-16 | 2017-11-03 | Astrazeneca Ab | Nanopartículas poliméricas terapéuticas y métodos para su fabricación y uso |
| JO3512B1 (ar) | 2014-03-26 | 2020-07-05 | Astex Therapeutics Ltd | مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز |
| JP6752715B2 (ja) | 2014-03-26 | 2020-09-09 | アステックス、セラピューティックス、リミテッドＡｓｔｅｘ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | 組合せ |
| MX373150B (es) | 2014-03-26 | 2020-04-21 | Astex Therapeutics Ltd | Combinaciones de un inhibidor del factor de crecimiento de fibroblasto (fgfr) y un inhibidor del receptor del factor de crecimiento 1 similar a insulina (igf1r). |
| TWI719960B (zh) | 2015-02-10 | 2021-03-01 | 英商阿斯迪克治療公司 | 新穎組成物 |
| US10478494B2 (en) | 2015-04-03 | 2019-11-19 | Astex Therapeutics Ltd | FGFR/PD-1 combination therapy for the treatment of cancer |
| AU2016328693B2 (en) | 2015-09-23 | 2021-03-11 | Janssen Pharmaceutica Nv | Bi-heteroaryl substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| DK3353177T3 (da) | 2015-09-23 | 2020-08-24 | Janssen Pharmaceutica Nv | Tricykliske heterocykler til behandling af cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60234125D1 (de) * | 2001-12-24 | 2009-12-03 | Astrazeneca Ab | E inhibitoren |
| ES2290529T3 (es) * | 2002-12-24 | 2008-02-16 | Astrazeneca Ab | Derivados de fosfonooxiquinazolina y su uso farmaceutico. |
-
2006
- 2006-05-16 GB GBGB0609621.8A patent/GB0609621D0/en not_active Ceased
-
2007
- 2007-05-10 TW TW096116652A patent/TW200813026A/zh unknown
- 2007-05-14 KR KR1020087029569A patent/KR20090009297A/ko not_active Withdrawn
- 2007-05-14 CA CA002650519A patent/CA2650519A1/en not_active Abandoned
- 2007-05-14 EP EP07732795A patent/EP2027114A1/en not_active Withdrawn
- 2007-05-14 RU RU2008149242/04A patent/RU2008149242A/ru not_active Application Discontinuation
- 2007-05-14 BR BRPI0712791-0A patent/BRPI0712791A2/pt not_active IP Right Cessation
- 2007-05-14 MX MX2008014550A patent/MX2008014550A/es active IP Right Grant
- 2007-05-14 JP JP2009510536A patent/JP2009537498A/ja active Pending
- 2007-05-14 AU AU2007251304A patent/AU2007251304A1/en not_active Abandoned
- 2007-05-14 UA UAA200813934A patent/UA95108C2/ru unknown
- 2007-05-14 SA SA07280243A patent/SA07280243B1/ar unknown
- 2007-05-14 WO PCT/GB2007/001771 patent/WO2007132227A1/en not_active Ceased
- 2007-05-14 CN CNA2007800179575A patent/CN101448823A/zh active Pending
- 2007-05-15 UY UY30351A patent/UY30351A1/es unknown
- 2007-05-15 US US11/748,651 patent/US7625910B2/en not_active Expired - Fee Related
- 2007-05-15 CL CL2007001388A patent/CL2007001388A1/es unknown
- 2007-05-16 AR ARP070102121A patent/AR060963A1/es not_active Application Discontinuation
-
2008
- 2008-10-23 IL IL194862A patent/IL194862A0/en unknown
- 2008-10-24 ZA ZA200809172A patent/ZA200809172B/xx unknown
- 2008-11-03 NO NO20084580A patent/NO20084580L/no not_active Application Discontinuation
- 2008-11-14 EC EC2008008890A patent/ECSP088890A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200809172B (en) | 2009-12-30 |
| JP2009537498A (ja) | 2009-10-29 |
| IL194862A0 (en) | 2009-08-03 |
| RU2008149242A (ru) | 2010-06-27 |
| AR060963A1 (es) | 2008-07-23 |
| UA95108C2 (en) | 2011-07-11 |
| MX2008014550A (es) | 2008-11-27 |
| EP2027114A1 (en) | 2009-02-25 |
| BRPI0712791A2 (pt) | 2012-09-04 |
| WO2007132227A1 (en) | 2007-11-22 |
| CA2650519A1 (en) | 2007-11-22 |
| TW200813026A (en) | 2008-03-16 |
| US7625910B2 (en) | 2009-12-01 |
| KR20090009297A (ko) | 2009-01-22 |
| ECSP088890A (es) | 2008-12-30 |
| GB0609621D0 (en) | 2006-06-21 |
| SA07280243B1 (ar) | 2010-12-01 |
| UY30351A1 (es) | 2008-01-02 |
| CN101448823A (zh) | 2009-06-03 |
| NO20084580L (no) | 2009-02-05 |
| AU2007251304A1 (en) | 2007-11-22 |
| US20080045481A1 (en) | 2008-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2007001388A1 (es) | Co-cristal de maleato de 2{etil[3-({4-[(5-{2-[(3-fluorfenil)amino]-2-oxoetil}-1h-pirazol-3-il)amino]quinazolin-7-il}oxi)propil]amino}fosfato dihidrogeno de etilo (azd1152), inhibidor de aurora quinasa; metodo de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades hiperproliferativas como el cancer. | |
| BRPI0622054B8 (pt) | composto e composição farmacêutica | |
| BRPI0720551A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
| BRPI0610321B8 (pt) | imidazoquinolinas como inibidores de lipídeo cinase, seu uso e seu processo de preparação, e preparação farmacêutica | |
| TW200615266A (en) | Organic compounds | |
| CL2007000789A1 (es) | Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer. | |
| EA200802390A1 (ru) | Конъюгаты аналогов азиридилэпотилона и фармацевтические композиции, содержащие их | |
| CR20110016A (es) | Compuestos quimicos 251 | |
| BRPI0507198A (pt) | derivados de bisariluréia | |
| NO20070656L (no) | 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft | |
| IL188475A0 (en) | Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors | |
| NO20070655L (no) | 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft | |
| ECSP088329A (es) | Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8 | |
| NO20082088L (no) | Azetidiner som MEK-inhibitorer for behandling av proliferative sykdommer | |
| BRPI0610850A2 (pt) | derivados de Ácido aril alquila, composiÇço farmacÊutica, medicamento, bem como uso dos referidos derivados | |
| BRPI0509172A (pt) | pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento | |
| GT200800184A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes. | |
| NO20081050L (no) | Kaspaseinhibitor-prodroger | |
| BRPI0717907A2 (pt) | "composto, composição farmacêutica, métodos para tratar um câncer, para inbir ou modular a atividade da lipídeo quinase, processo para a produçãoo de uma composição farmacêutica, uso de um composto e kit" | |
| WO2008032072A8 (en) | 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders | |
| BRPI0517803A (pt) | pirazolpirimidinas 1,4-substituìdas como inibidores de cinase | |
| WO2006044497A3 (en) | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease | |
| CL2008000021A1 (es) | Compuestos derivados de 2,4-dianilinopirimidinas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y cancer. | |
| BR0315580A (pt) | Derivados de metileno uréia | |
| MX2009004017A (es) | Usos de los compuestos carboxi-amido triazol y sus sales. |